List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type (2022-2028)
1.2.2 Commercial Assays/Tests
1.2.3 Laboratory Developed Tests
1.2.4 Direct to Consumer Test
1.2.5 Pre-Commercial Tests
1.3 Market by Application
1.3.1 Global NGS-Based Monitoring and Diagnostic Test Market Share by Application (2022-2028)
1.3.2 Out-Patient Clinics/General Practitioners
1.3.3 Diagnostic Centers
1.3.4 Hospitals
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global NGS-Based Monitoring and Diagnostic Test Market Size
2.2 NGS-Based Monitoring and Diagnostic Test Market Size by Regions
2.2.1 NGS-Based Monitoring and Diagnostic Test Growth Rate by Regions (2022-2028)
2.2.2 NGS-Based Monitoring and Diagnostic Test Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 NGS-Based Monitoring and Diagnostic Test Revenue by Players (2022 & 2028)
3.2 NGS-Based Monitoring and Diagnostic Test Key Players Headquarters and Area Served
3.3 Key Players NGS-Based Monitoring and Diagnostic Test Product/Solution/Service
3.4 Date of Enter into NGS-Based Monitoring and Diagnostic Test Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global NGS-Based Monitoring and Diagnostic Test Market Size by Type (2022-2028)
4.2 Global NGS-Based Monitoring and Diagnostic Test Market Size by Application (2022-2028)
5 North America
5.1 North America NGS-Based Monitoring and Diagnostic Test Market Forecast (2022-2028)
5.2 NGS-Based Monitoring and Diagnostic Test Key Players in North America
5.3 North America NGS-Based Monitoring and Diagnostic Test Market Size by Type
5.4 North America NGS-Based Monitoring and Diagnostic Test Market Size by Application
6 Europe
6.1 Europe NGS-Based Monitoring and Diagnostic Test Market Forecast (2022-2028)
6.2 NGS-Based Monitoring and Diagnostic Test Key Players in Europe
6.3 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type
6.4 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Forecast (2022-2028)
7.2 NGS-Based Monitoring and Diagnostic Test Key Players in Asia-Pacific
7.3 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Type
7.4 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America NGS-Based Monitoring and Diagnostic Test Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Player Profiles
9.1 Agilent Technologies, Inc.
9.1.1 Agilent Technologies, Inc. Company Details
9.1.2 Agilent Technologies, Inc. Description and Business Overview
9.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.1.4 Agilent Technologies, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.1.5 Agilent Technologies, Inc. Recent Development
9.2 Ancestry.com LLC
9.2.1 Ancestry.com LLC Company Details
9.2.2 Ancestry.com LLC Description and Business Overview
9.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Introduction
9.2.4 Ancestry.com LLC Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.2.5 Ancestry.com LLC Recent Development
9.3 ArcherDX, Inc.
9.3.1 ArcherDX, Inc. Company Details
9.3.2 ArcherDX, Inc. Description and Business Overview
9.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.3.4 ArcherDX, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.3.5 ArcherDX, Inc. Recent Development
9.4 Beijing Genomics Institute (BGI)
9.4.1 Beijing Genomics Institute (BGI) Company Details
9.4.2 Beijing Genomics Institute (BGI) Description and Business Overview
9.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Introduction
9.4.4 Beijing Genomics Institute (BGI) Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.4.5 Beijing Genomics Institute (BGI) Recent Development
9.5 Cancer Genetics, Inc.
9.5.1 Cancer Genetics, Inc. Company Details
9.5.2 Cancer Genetics, Inc. Description and Business Overview
9.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.5.4 Cancer Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.5.5 Cancer Genetics, Inc. Recent Development
9.6 CENTOGENE AG
9.6.1 CENTOGENE AG Company Details
9.6.2 CENTOGENE AG Description and Business Overview
9.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Introduction
9.6.4 CENTOGENE AG Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.6.5 CENTOGENE AG Recent Development
9.7 F. Hoffmann-La Roche Ltd
9.7.1 F. Hoffmann-La Roche Ltd Company Details
9.7.2 F. Hoffmann-La Roche Ltd Description and Business Overview
9.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Introduction
9.7.4 F. Hoffmann-La Roche Ltd Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.7.5 F. Hoffmann-La Roche Ltd Recent Development
9.8 GenePath Dx
9.8.1 GenePath Dx Company Details
9.8.2 GenePath Dx Description and Business Overview
9.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Introduction
9.8.4 GenePath Dx Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.8.5 GenePath Dx Recent Development
9.9 Illumina, Inc.
9.9.1 Illumina, Inc. Company Details
9.9.2 Illumina, Inc. Description and Business Overview
9.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.9.4 Illumina, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.9.5 Illumina, Inc. Recent Development
9.10 Laboratory Corporation of America Holdings
9.10.1 Laboratory Corporation of America Holdings Company Details
9.10.2 Laboratory Corporation of America Holdings Description and Business Overview
9.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Introduction
9.10.4 Laboratory Corporation of America Holdings Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.10.5 Laboratory Corporation of America Holdings Recent Development
9.11 Myriad Genetics, Inc.
9.11.1 Myriad Genetics, Inc. Company Details
9.11.2 Myriad Genetics, Inc. Description and Business Overview
9.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.11.4 Myriad Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.11.5 Myriad Genetics, Inc. Recent Development
9.12 QIAGEN N.V.
9.12.1 QIAGEN N.V. Company Details
9.12.2 QIAGEN N.V. Description and Business Overview
9.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Introduction
9.12.4 QIAGEN N.V. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.12.5 QIAGEN N.V. Recent Development
9.13 Quest Diagnostics Incorporated
9.13.1 Quest Diagnostics Incorporated Company Details
9.13.2 Quest Diagnostics Incorporated Description and Business Overview
9.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Introduction
9.13.4 Quest Diagnostics Incorporated Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.13.5 Quest Diagnostics Incorporated Recent Development
9.14 Siemens Healthineers, Inc.
9.14.1 Siemens Healthineers, Inc. Company Details
9.14.2 Siemens Healthineers, Inc. Description and Business Overview
9.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.14.4 Siemens Healthineers, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.14.5 Siemens Healthineers, Inc. Recent Development
9.15 Thermo Fisher Scientific Inc.
9.15.1 Thermo Fisher Scientific Inc. Company Details
9.15.2 Thermo Fisher Scientific Inc. Description and Business Overview
9.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.15.4 Thermo Fisher Scientific Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.15.5 Thermo Fisher Scientific Inc. Recent Development
9.16 HTG Molecular Diagnostics, Inc.
9.16.1 Company Details
9.16.2 HTG Molecular Diagnostics, Inc. Description and Business Overview
9.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.16.4 HTG Molecular Diagnostics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.16.5 HTG Molecular Diagnostics, Inc. Recent Development
9.17 Vela Diagnostics Pte. Ltd.
9.17.1 Vela Diagnostics Pte. Ltd. Company Details
9.17.2 Vela Diagnostics Pte. Ltd. Description and Business Overview
9.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Introduction
9.17.4 Vela Diagnostics Pte. Ltd. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2022 & 2028)
9.17.5 Vela Diagnostics Pte. Ltd. Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
